The Neuroprotective Effect of NEUROMIDE, a Compound Bioidentical to Commensal Bacteria Metabolites
GPR119 is a novel cannabinoid receptor that is primarily expressed in the pancreas and gastrointestinal tract and has beneficial effects on glucose homeostasis exerted through the stimulation of GLP-1 secretion, as demonstrated in the rodent brain. GLP-1 also has important anti-inflammatory effects...
Main Authors: | Yoonhee Seo, Hyunji Tak, Dohee Park, Hyejin Song, Sooyoung Choe, Chaehyeong Park, Byeongdeog Park |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/10/1529 |
Similar Items
-
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
by: Miriam Melis, et al.
Published: (2006-10-01) -
Cannabinoid Modulation of the Stressed Hippocampus
by: Franciele F. Scarante, et al.
Published: (2017-12-01) -
Evaluation of cannabinoid receptors type 1–2 in periodontitis patients
by: Atefe Ataei, et al.
Published: (2022-10-01) -
CB2 and GPR55 receptors as therapeutic targets for systemic immune dysregulation
by: Juan Zhou, et al.
Published: (2016-08-01) -
Isoprenoid Derivatives of Lysophosphatidylcholines Enhance Insulin and GLP-1 Secretion through Lipid-Binding GPCRs
by: Anna Drzazga, et al.
Published: (2021-05-01)